Cooper Companies Inc
NYSE:COO
Cooper Companies Inc
Capital Expenditures
Cooper Companies Inc
Capital Expenditures Peer Comparison
Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors
Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Cooper Companies Inc
NYSE:COO
|
Capital Expenditures
-$427.6m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-7%
|
|
Haemonetics Corp
NYSE:HAE
|
Capital Expenditures
-$66.3m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
11%
|
CAGR 10-Years
1%
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Capital Expenditures
-$144m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-3%
|
|
Align Technology Inc
NASDAQ:ALGN
|
Capital Expenditures
-$177.7m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-25%
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Capital Expenditures
-$119m
|
CAGR 3-Years
-113%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
-37%
|
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
Capital Expenditures
-$36.4m
|
CAGR 3-Years
4%
|
CAGR 5-Years
12%
|
CAGR 10-Years
3%
|
See Also
What is Cooper Companies Inc's Capital Expenditures?
Capital Expenditures
-427.6m
USD
Based on the financial report for Jan 31, 2024, Cooper Companies Inc's Capital Expenditures amounts to -427.6m USD.
What is Cooper Companies Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-7%
Over the last year, the Capital Expenditures growth was -60%. The average annual Capital Expenditures growth rates for Cooper Companies Inc have been -13% over the past three years , -14% over the past five years , and -7% over the past ten years .